ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

$ 7.00

4.7 (565) In stock

Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint Neuro Maestro Brain Model Comparative Reproducibility Error Results Reproducibility error of Maestro (green), FreeSurfer 7.2 (blue) and manual segmentation (red) for common brain structures (left), and average over all structures (right). Bars represent range of measured relative volume difference. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NE
Clinical Validation of the Brain Model Published Online in the Journal NeuroImage ClearPoint Maestro Brain Model ClearPoint Maestro Brain Model ClearPoint

Press Release Distribution and Management

SNN

SNN

SNN

ClearPoint Neuro, Inc. on LinkedIn: #sfn22 #clpt #neuroscience

Jacqueline Keller on LinkedIn: UC San Diego Health among First in Nation to Perform Regenerative Brain…

EarlyBirds Maps Out the Net Zero Innovation Landscape for a Greener Future - 新浪香港

SNN

Jacqueline Keller on LinkedIn: Two great pieces of news: 1) FDA clearance and FIH for our new 2.2…

ClearPoint Neuro, Inc. on LinkedIn: #employeehighlight #productionlead #clearpointneuro #clpt #teamappreciation

Stock Market News 2024-02-21